

Your fight against advanced
kidney cancer may start or continue here
OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)
Your fight against advanced
kidney cancer may start or continue here
OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)
Actor portrayals.
OPDIVO + YERVOY is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)
OPDIVO, in combination with CABOMETYX® (cabozantinib), is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)
OPDIVO is a treatment option for certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications
You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO
OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO, OPDIVO-based combination treatments, OPDIVO Qvantig, and OPDIVO Qvantig-based combination treatments will not work for everyone. Individual results may vary.
We have answers about getting treatment, monitoring, and more